Form 8-K - Current report:
SEC Accession No. 0001140361-24-012513
Filing Date
2024-03-11
Accepted
2024-03-11 09:27:59
Documents
14
Period of Report
2024-03-08
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K ef20023812_8k.htm   iXBRL 8-K 24783
  Complete submission text file 0001140361-24-012513.txt   158242

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA insm-20240308.xsd EX-101.SCH 3859
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE insm-20240308_lab.xml EX-101.LAB 21966
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE insm-20240308_pre.xml EX-101.PRE 16040
15 EXTRACTED XBRL INSTANCE DOCUMENT ef20023812_8k_htm.xml XML 4065
Mailing Address 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807
Business Address 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807 908-977-9900
INSMED Inc (Filer) CIK: 0001104506 (see all company filings)

EIN.: 541972729 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30739 | Film No.: 24736758
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)